Bob Storey is a managing partner at The LaunchPort™, a medtech manufacturing accelerator. He has extensive experience in working with NIH initiatives in innovation and investment. He is one of the eight national portfolio managers for the NIBIB RADx program and has been the sole medical device instructor for the biannual national NIH I-Corps program since its inception in 2014. These activities, combined with operations of LaunchPort, have resulted in the assessment of hundreds of early stage medtech and life sciences companies and technologies each year. Storey’s involvement with Johns Hopkins University and its School of Medicine has included a number of neuroscience and technology deployments. LaunchPort, under Storey’s leadership, will support NeuroTech Harbor’s equitech vision and its innovators.
Adler Archer is the Managing Director of the Inclusive Innovation Initiative (i3) and an associate research scientist of Biomedical Engineering with a joint appointment in Medicine and courtesy appointment in business. As a research scientist at the Johns Hopkins Center for Bioengineering Innovation and Design, Dr Archer’s research focuses on the implementation of technology in community healthcare settings, community-based participatory research, and social informatics. Adler teaches digital health innovation and regulatory science courses at the Johns Hopkins University School of Medicine and teaches business leadership and human values courses at Johns Hopkins Carey Business School.
Kebreten Manaye is a Professor and Chair of Physiology and Biophysics at one of the premier Historically Black Colleges and Universities (HBCUs). Kebreten is the past Director of Graduate Studies in her department and has enhanced the participation of minorities in cutting-edge STEM programs. She is co-PI of the NIH-funded Howard University Advancing Diversity in Aging Research (HUADAR) program that identifies bright minority students from STEM disciplines early during their undergraduate years. She prepares them to successfully compete for graduate studies and other professional careers through extensive mentoring and training. She also has contributed to the Center for Brains, Minds, and Machines (CBMM), one of the NSF Science and Technology Centers, and has trained and mentored promising students through the Step-Up NIH program for two decades. Dr. Manaye is a gifted mentor to her students and faculty and foster diversity and equity in medical school. She will serve as NTH PI. Dr. Manaye and the team’s major role is to increase the number of women and URMs innovators through outreach and education, and to enhance equity and accessibility of neuromedical solutions. This program will expand diversity amongst neurotech innovators and increase participation by women, Black, LatinX, and communities of color. Dr. Manaye received numerous teaching and research awards. Recently she was elected as the first black woman to serve effective 2023 as the President of the Association of Chairs of Physiology Departments.
Evaristus Nwulia, M.D. MHS, is a Johns Hopkins trained physician and a neuroscientist, with over 15 years history in leading educational and training programs aimed at enhancing representation of underrepresented minority STEM and MD-Ph.D. students from HBCUs in the neuroscience workforce. He is also a professor neuroscience, who pioneered the development of home-based olfactory sensory stimulation platforms as disease modifying interventions for early Alzheimer’s disease. He holds several patents for devices and drugs, and for olfactory transcellular drug delivery methods for CNS disorders. He is co-Founder of three neuromedical device companies, including Evon Medics LLC, a neuroTech company tackling neurodegenerative diseases, traumatic brain injuries and chronic pain; with over 65% employees from URM populations, Evon Medics has become a harbor for nurturing career development of highly talented young minority innovators. Evaristus has been a member of several NIH neuroscience-based scientific peer review panels over the past 10 years and has chaired the NIH Fogarty Global Brain Disorders Special Emphasis Panel. Ergo, he has extensive experience for recognition of projects with potential transformative impact. As a Neuroethicist and Chair of the institutional ethics committee board at Howard University, he brings substantial expertise in the ethical, legal, and societal implications of neuroscience and neurotech devices, particularly from the standpoint of several under-represented minority populations.